- Treatment & Clinical Trials
- Latest News
- In the News
- Current Research
Treatment & Clinical Trials
Dr. David Boulware's hydroxychloroquine trial on early outpatient treatment of COVID-19 has been published in the Annals of Internal Medicine. Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19
Dr. David Boulware discusses his Hydroxychloroquine trial on Open Forum Infectious Diseases podcast. How to Conduct a Clinical Trial During a Pandemic—An Interview with Dr. David Boulware
Donate to COVID-19 for preventing disease or treating early coronavirus
The Lancet Rheumatology: Excitement around hydroxychloroquine for treating COVID-19 causes challenges for rheumatology
NPR.org: Clinical trials set to determine if Anti-Malaria Drug is effective against COVID-19
Dr. Susan Kline, Using Science to Find Solutions. Read Feature.
Minnesota Monthly honors Dr. Winston Cavert, Dr. Susan Kline, Dr. Meghan Rothenberber and Dr. Jo-Anne Young in 2020 Top Doctors.
Christen Ebens, MD, MPH, in the Department of Pediatrics, and Meghan Rothenberger, MD, in the Department of Medicine, co-lead the U of M site for an international study collecting samples from some of COVID-19’s most unexpected, yet sickest, patients. The research will determine if genetics plays a role in who falls ill with the disease. Read Story.
Dr. Joshua Rhein discusses with Star Tribune, natural killer cells also have antiviral properties that could work against COVID-19.
Read about Dr. Joshua Rhein’s clinical trial “Study of FT516 Safety and Feasibility for the Treatment of Coronavirus Disease 2019 (COVID-19) in Hospitalized Patients with Hypoxia,"
COVID-19 and Dexamethasone A Potential Strategy to Avoid Steroid-Related Strongyloides Hyperinfection. Read Article, by Dr. William Stauffer, et. al.
A COVID-19 Vaccine Doesn’t Exist Yet. When Will We Get One?
Listen to our own Timothy Schacker, MD, Vice Dean for Research (pictured left) discuss the quest for a COVID-19 vaccine on this NPR program. Story
Officials say COVID-19 antibody testing is crucial to reopening business — but what is it? Dr. Timothy Schacker discusses antibody testing. Read Story
How Many COVID-19 Patients Do Not Show Symptoms? Dr. Susan Kline discusses transmission of COVID in Asymptomatic patients. Read Story
Dr. Hart Featured: U Medical School Studying How to Protect Against Current, Future Strains of the Coronavirus
Dr. Timothy Schacker discusses the use of dexamethasone for COVID treatment in an article in Star Tribune UK study backs HCMC’s bullish use of dexamethasone for covid-19
Dr. David Boulware discusses his hydroxychloroquine study results in an article by US News FDA pulls emergency approval of hydroxychloroquine for covid-19
Is Minnesosta experiencing a resurgence of covid-19 infections, after recent protests? Dr. Sarah Lofgren weighs in on Sirius XM Doctor Radio Reports. Listen to Clip
How reliable are covid-19 tests? Dr. Timothy Schacker discusses testing in an article by iNEWS
COVID-19: What do we know about asymptomatic transmission? Dr. Timothy Schacker is interviewed by Kare 11
Dr. Boulware’s hydroxycholorquine study results are discussed in Science Magazine Three big studies dim hopes that hydroxychloroquine can treat or prevent COVID-19
What do the George Flyod autopsies show?Dr. Susan Kline is interviewed by MPR News. Listen to Recording
Regis works with infectious disease specialists at the University of Minnesota Medical School to enhance customer and stylist safety measures for salon operations Dr. Joshua Rhein and Dr. Mahsa Abassi provide safety recommendations for re-opening of Regis Salons
Officials say public compliance key as virus enters ‘volatile phase’ in Minnesota Star Tribune discusses Dr. Susan Kline’s remdesivir study
In the News
Dr. Susan Kline is featured on the UMN Medical School website "Uses Research Network to Find Effective Treatments for COVID-19"
Dr. Sarah Lofgren interviewed on Fox News "New trials underway to determine potential benefits of hydroxychloroquine"
Dr. Radha Rajasingham featured on Facebook CNN Replay. Specialist says hydroxychloroquine should only be taken for Covid-19 in trial setting.
MPR News discusses with Dr. Susan Kline some guidelines to follow with the loosening of COVID restrictions. Want to see friends and family, now that COVID-19 restrictions are loosening? Here’s what to consider.
Dr. Timothy Schacker discusses how the state has the capacity to test more people. Read the Star Tribune article: Health officials encourage more Minnesotans to seek testing for COVID-19
The Twin Cities Pioneer Press discusses Dr. Susan Kline’s Remdesivir study and secondary study, the combination of an anti-viral drug and anti-inflammatory Baricitinid to determine if it will improve lung-function. U of M physician at forefront of remdesivir trials test anti-inflammatory drug combo
Channel 5 News interviews Dr. Timothy Schacker on Gov. Walz goal to meet 20,000 testing per day. Watch video: University of Minnesota working to ramp up testing to meet Gov. Walz 20,000 test per day goal
Dr. Tim Schacker interviewed by NewsUS about COVID-19 testing. The article casts doubt that the U.S. will be able to succeed without federal coordination of state and private efforts No leadership and no plan: is Trump about to fail the US on coronavirus testing?
Watch Video: Drs. Bill Stauffer and Jon Hallberg, UMN Center for Global Health and Social Responsibility and famed cellist Yo-Yo Ma collaborated to create a video to celebrate healthcare first responders in our community and worldwide
Fox 9 News: COVID-19 clinical trial launches at U of M; researchers hope to find new use for old malaria drug. Interview with Dr. Caleb Skipper
Independent: Coronavirus Scientists urge caution as they scramble to test Trump’s ‘game-changer’ cure
ND Newscast: Dr. Caleb Skipper featured in local newscast
Dr. Tyler Bold’s Lab is conducting research on antibody prevention of reinfection in his study SERUM SARS-COV-2 NEUTRALIZATION ACTIVITY. Learn More
A study led by Infectious Diseases Dr. Geoffrey Hart and Dr. Marco Pravetoni (Pharmacology): Understanding Protective Antibody Mechanisms in COVID-19 to Engineer Universal Coronavirus Vaccine. Learn More
About our Division
- Talented Faculty
- Opportunities for Fellows
- Think & Act Globally
The Division of Infectious Diseases and International Medicine (IDIM) has more than 50 faculty overseeing programs in clinical care, education, and research at five teaching hospitals affiliated with the University of Minnesota Medical School: University of Minnesota Medical Center (UMMC), Minneapolis VA Health Care System, Hennepin County Medical Center, Regions Hospital, and Abbott Northwestern Hospital.
Each of these institutions serves somewhat different patient populations, and the clinical and research programs at these sites together with opportunities in global health, provide a remarkable breadth of expertise and academic experiences for trainees in the IDIM Division.
Research & Collaboration
In addition to our clinical scholars and physician scientists with clinical responsibilities, five full-time research faculty contribute importantly to the research mission of our division. The Center for Infectious Diseases and Microbiology Translational Research, an interdisciplinary research center, is the base of operation for these faculty members. Epidemiological research is carried out with colleagues in the School of Public Health, which helps administrate the division’s NIH-funded MPH/MSc-related training program. The Division also benefits from collaborations with faculty members who hold joint academic appointments in other departments, colleagues in the Center for Infectious Diseases Research and Policy, the College of Veterinary Medicine, the Minnesota Department of Health, and a number of community-based Infectious Diseases faculty.
Opportunities for Fellows
Opportunities for Fellows
During their research training, Infectious Diseases Fellows can enter an NIH-supported epidemiology (MPH)/clinical research (MSc) pathway coordinated by the School of Public Health, or they can select a laboratory-based research project at several training sites, including the Center for Translational Research in Microbiology and Infectious Diseases.
Think & Act Globally
Think & Act Globally
Because of a large influx of immigrants to Minnesota and increasing challenges from emerging infections here and abroad, especially in developing countries, our goal is to: "Think and act locally and globally."
ID Intercity Clinical Case Conference
About this Conference
The ID Intercity Clinical Case Conference is a regularly scheduled didactic session, sponsored by the Infectious Diseases Division in the Department of Medicine. Presenters are invited from the University of Minnesota, the Minnesota Department of Health and the ID community.
Held weekly on Tuesday mornings throughout the year (with the exception of July), case presentations are interactive and frequently presented as “unknowns,” encouraging discovery and participation with the audience in diagnosis and treatment remedies. Fellows, residents, students, faculty and members of the ID community all present and participate. This series is open to the public and sessions are streamed live and often recorded.
Dr. Jo-Anne Young is the conference director and Betsy Wehrwein is the organizer. For further information, please contact firstname.lastname@example.org.